US Physical Therapy Inc (USPH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 27.95 is considered Undervalued compared with the five-year average of 34.51. The fair price of US Physical Therapy Inc (USPH) is between 91.50 to 114.19 according to relative valuation method. Compared to the current price of 83.03 USD , US Physical Therapy Inc By Undervalued By 9.26%.

Relative Value

Fair Zone

91.50-114.19

Current Price：83.03

9.26%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is US Physical Therapy Inc (USPH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

US Physical Therapy Inc (USPH) has a current Price-to-Book (P/B) ratio of 2.38. Compared to its 3-year average P/B ratio of 2.94, the current P/B ratio is approximately -19.04% higher. Relative to its 5-year average P/B ratio of 3.58, the current P/B ratio is about -33.41% higher. US Physical Therapy Inc (USPH) has a Forward Free Cash Flow (FCF) yield of approximately 4.74%. Compared to its 3-year average FCF yield of 4.72%, the current FCF yield is approximately 0.45% lower. Relative to its 5-year average FCF yield of 4.94%, the current FCF yield is about -4.02% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for USPH competitors is 1.19, providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH.N) exhibits a P/S ratio of 1.47, which is 23.62% above the industry average. Given its robust revenue growth of 12.35%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of USPH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of USPH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is USPH currently overvalued or undervalued?

What is US Physical Therapy Inc (USPH) fair value?

USPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of US Physical Therapy Inc (USPH) is between 91.50 to 114.19 according to relative valuation method.

How does USPH's valuation metrics compare to the industry average?

The average P/S ratio for USPH's competitors is 1.19, providing a benchmark for relative valuation. US Physical Therapy Inc Corp (USPH) exhibits a P/S ratio of 1.47, which is 23.62% above the industry average. Given its robust revenue growth of 12.35%, this premium appears unsustainable.

What is the current P/B ratio for US Physical Therapy Inc (USPH) as of Mar 03 2026?

As of Mar 03 2026, US Physical Therapy Inc (USPH) has a P/B ratio of 2.38. This indicates that the market values USPH at 2.38 times its book value.

What is the current FCF Yield for US Physical Therapy Inc (USPH) as of Mar 03 2026?

As of Mar 03 2026, US Physical Therapy Inc (USPH) has a FCF Yield of 4.74%. This means that for every dollar of US Physical Therapy Inc's market capitalization, the company generates 4.74 cents in free cash flow.

What is the current Forward P/E ratio for US Physical Therapy Inc (USPH) as of Mar 03 2026?

As of Mar 03 2026, US Physical Therapy Inc (USPH) has a Forward P/E ratio of 27.95. This means the market is willing to pay $27.95 for every dollar of US Physical Therapy Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for US Physical Therapy Inc (USPH) as of Mar 03 2026?

As of Mar 03 2026, US Physical Therapy Inc (USPH) has a Forward P/S ratio of 1.47. This means the market is valuing USPH at $1.47 for every dollar of expected revenue over the next 12 months.

USPH Valuation